Adaptive Biotechnologies Acquires Sequenta, Could Disrupt Disease Detection

Adaptive Biotechnologies Corporation is buying Sequenta Inc. for an undisclosed sum to create a new company that uses powerful immunosequencing techniques to diagnose and fight cancer, infectious diseases, and autoimmune disorders.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news